A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of A Topical Estradiol Ophthalmic Formulation in Post-Menopausal Women With Moderate-To-Severe Dry Eye Disease
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).